Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin Signature
暂无分享,去创建一个
Salam A. Assi | D. Westhead | Jason Piper | S. Ott | P. Cauchy | C. Bonifer | P. Cockerill | S. Akiki | M. Raghavan | Joaquin Zacarias-Cabeza | S. R. James | A. Ptasinska | M. Imperato | M. Canestraro | M. Hoogenkamp | J. Loke | S. Clokie | S. Richards | M. Griffiths | Joaquin Zacarías-Cabeza
[1] M. F. Shannon,et al. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[2] W. Leonard,et al. Essential Role of Signal Transducer and Activator of Transcription (Stat)5a but Not Stat5b for Flt3-Dependent Signaling , 2000, The Journal of experimental medicine.
[3] R. Muise-Helmericks,et al. Signal transduction and the Ets family of transcription factors , 2000, Oncogene.
[4] W. Berdel,et al. Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. , 2000, Blood.
[5] M. Karin,et al. AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.
[6] D. Gilliland,et al. FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model. , 2002, Blood.
[7] G. Ehninger,et al. Analysis of Flt3-activating Mutations in 979 Patients with Acute Myelogenous Leukemia: Association with Fab Subtypes and Identification of Subgroups with Poor Prognosis , 2022 .
[8] C. Miething,et al. Sensitivity toward tyrosine kinase inhibitors varies between different activating mutations of the FLT3 receptor. , 2003, Blood.
[9] J. Radich,et al. The role of FLT3 in haematopoietic malignancies , 2003, Nature Reviews Cancer.
[10] S Miyano,et al. Open source clustering software. , 2004, Bioinformatics.
[11] Alok J. Saldanha,et al. Java Treeview - extensible visualization of microarray data , 2004, Bioinform..
[12] Gordon K. Smyth,et al. Use of within-array replicate spots for assessing differential expression in microarray experiments , 2005, Bioinform..
[13] V. Giancotti. Breast cancer markers. , 2006, Cancer letters.
[14] A. Bert,et al. A Modular Enhancer Is Differentially Regulated by GATA and NFAT Elements That Direct Different Tissue-Specific Patterns of Nucleosome Positioning and Inducible Chromatin Remodeling , 2007, Molecular and Cellular Biology.
[15] S. Fröhling,et al. Deregulation of signaling pathways in acute myeloid leukemia. , 2008, Seminars in oncology.
[16] C. Preudhomme,et al. Cooperating gene mutations in acute myeloid leukemia: a review of the literature , 2008, Leukemia.
[17] T. Golub,et al. Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cells. , 2008, Blood.
[18] Jinshui Fan,et al. Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML. , 2008, Blood.
[19] Kristina Masson,et al. Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3. , 2009, Cellular signalling.
[20] Andrew J. Bannister,et al. JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin , 2009, Nature.
[21] Bas J. Wouters,et al. Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling , 2009, Haematologica.
[22] H. Lodish,et al. ID1 promotes expansion and survival of primary erythroid cells and is a target of JAK2V617F-STAT5 signaling. , 2009, Blood.
[23] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[24] Kai Ye,et al. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..
[25] David S. Lapointe,et al. ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data , 2010, BMC Bioinformatics.
[26] C. Glass,et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.
[27] W. Ouwehand,et al. Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. , 2010, Cell stem cell.
[28] Aaron R. Quinlan,et al. BIOINFORMATICS APPLICATIONS NOTE , 2022 .
[29] T. Mikkelsen,et al. The NIH Roadmap Epigenomics Mapping Consortium , 2010, Nature Biotechnology.
[30] E. Shaulian. AP-1--The Jun proteins: Oncogenes or tumor suppressors in disguise? , 2010, Cellular signalling.
[31] A. Tanay,et al. Dynamic combinatorial interactions of RUNX1 and cooperating partners regulates megakaryocytic differentiation in cell line models. , 2011, Blood.
[32] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[33] Brent S. Pedersen,et al. Pybedtools: a flexible Python library for manipulating genomic datasets and annotations , 2011, Bioinform..
[34] S. Gygi,et al. Survey of Activated FLT3 Signaling in Leukemia , 2011, PloS one.
[35] W. Wiktor-Jedrzejczak,et al. Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse. , 2011, Blood.
[36] M. Gut,et al. Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters , 2011, Nature Structural &Molecular Biology.
[37] P. Cockerill. Structure and function of active chromatin and DNase I hypersensitive sites , 2011, The FEBS journal.
[38] J. Carroll,et al. Pioneer transcription factors: establishing competence for gene expression. , 2011, Genes & development.
[39] M. Gut,et al. Supplemental information for : “ CpG islands and GC content dictate nucleosome depletion in a transcription independent manner at mammalian promoters ” , 2012 .
[40] H. Klein,et al. Leukemia Gene Atlas – A Public Platform for Integrative Exploration of Genome-Wide Molecular Data , 2012, PloS one.
[41] H. Stunnenberg,et al. ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia. , 2012, Blood.
[42] Shane J. Neph,et al. An expansive human regulatory lexicon encoded in transcription factor footprints , 2012, Nature.
[43] ENCODEConsortium,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[44] Salam A. Assi,et al. Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding , 2012, Leukemia.
[45] Chunaram Choudhary,et al. SOCS1 cooperates with FLT3-ITD in the development of myeloproliferative disease by promoting the escape from external cytokine control. , 2010, Blood.
[46] N. Speck,et al. Gata2 is required for HSC generation and survival , 2013, The Journal of experimental medicine.
[47] So Yeon Kwon,et al. Chronic growth factor receptor signaling and lineage inappropriate gene expression in AML: The polycomb connection , 2013, Cell cycle.
[48] Yang Shi,et al. Emerging roles for chromatin as a signal integration and storage platform , 2013, Nature Reviews Molecular Cell Biology.
[49] Benjamin J. Raphael,et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.
[50] C. Glass,et al. Impact of natural genetic variation on enhancer selection and function , 2013, Nature.
[51] M. Morgan,et al. Selection for Evi1 activation in myelomonocytic leukemia induced by hyperactive signaling through wild-type NRas , 2013, Oncogene.
[52] Jason Piper,et al. Wellington: a novel method for the accurate identification of digital genomic footprints from DNase-seq data , 2013, Nucleic acids research.
[53] Salam A. Assi,et al. Identification of a Dynamic Core Transcriptional Network in t(8;21) AML that Regulates Differentiation Block and Self-Renewal , 2014, Cell reports.
[54] I. Weissman,et al. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission , 2014, Proceedings of the National Academy of Sciences.
[55] A. Bosserhoff,et al. AP-1/c-Jun transcription factors: regulation and function in malignant melanoma. , 2014, European journal of cell biology.
[56] R. Majeti,et al. Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis , 2014, Leukemia.
[57] J. Martens,et al. The genome-wide molecular signature of transcription factors in leukemia. , 2014, Experimental hematology.
[58] R. Siebert,et al. Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma , 2014, Proceedings of the National Academy of Sciences.
[59] G. Huang,et al. Posttranslational modifications of RUNX1 as potential anticancer targets , 2014, Oncogene.
[60] D. Tenen,et al. NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia , 2014, Leukemia.
[61] H. Martin,et al. Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis. , 2014, Cell reports.